Effect of a histone deacetylase inhibitor on human cardiac mass

Cardiovasc Drugs Ther. 2005 Jan;19(1):89-90. doi: 10.1007/s10557-005-6901-7.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antineoplastic Agents* / administration & dosage
  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Depsipeptides* / administration & dosage
  • Depsipeptides* / adverse effects
  • Depsipeptides* / therapeutic use
  • Echocardiography
  • Enzyme Inhibitors* / administration & dosage
  • Enzyme Inhibitors* / adverse effects
  • Enzyme Inhibitors* / therapeutic use
  • Heart / drug effects*
  • Histone Deacetylase Inhibitors*
  • Humans
  • Neoplasms / drug therapy
  • Organ Size / drug effects

Substances

  • Antineoplastic Agents
  • Depsipeptides
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors